Although seasonal influenza vaccines block most predominant influenza types and
subtypes, humans still remain vulnerable to waves of seasonal and new potential pandemic …

Influenza virus causes acute respiratory infection in humans, and is a major public health
concern globally. Antibodies play a central role in host protection against influenza virus. We …

Influenza's propensity for antigenic drift and shift, and to elicit predominantly strain specific
antibodies (Abs) leaves humanity susceptible to waves of new strains with pandemic …

Background Pandemic influenza poses a serious threat to global health and the world
economy. While vaccines are currently under development, passive immunization could …

Influenza viruses are a continuous threat to human public health because of their ability to
evolve rapidly through genetic drift and reassortment. Three human monoclonal antibodies …

Background Human antibodies that interfere with the biological activity of haemagglutinins
(HAs) of influenza viruses have high potential as an antiviral agent. Methods Human single …

Influenza viruses of the H1N1, H2N2, and H3N2 subtypes have caused previous
pandemics. H2 influenza viruses represent a pandemic threat due to continued circulation in …

Broadly cross-reactive antibodies (Abs) that recognize conserved epitopes within the
influenza virus hemagglutinin (HA) stalk domain are of particular interest for their potential …

Influenza A virus continuously infects humans and the antigenic shifts of this respiratory virus
enable it to cross the species barrier, threatening public health with the risk of pandemics …

Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …